Sign in

CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972-2-532-7151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 25,014 shares (grant or award)
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13D Stake Beneficial Ownership Report
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 8-K Event Material agreement · Unregistered share sale · Executive or director change
  12. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  13. 4 Grant or award Chief Executive Officer acquired 420,560 shares (grant or award)
  14. DEFA14A Proxy Proxy Materials
  15. ARS Other Annual Report to Security Holders
  16. DEF 14A Proxy Proxy Statement
  17. EFFECT Other Notice of Effectiveness
  18. 424B3 Offering Prospectus
  19. PRE 14A Proxy Proxy Statement (Preliminary)
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 2 of 21 · 420 filings